- Tytuł:
- Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial
- Autorzy:
- Źródło:
- The Lancet; May 2011, Vol. 377 Issue: 9780 p1846-1854, 9p
Periodyk